Scholarlink

Background <p>Facial aesthetics are profoundly influenced by the chin, a central feature that shapes harmony, projection, and perceived attractiveness. As demand for minimally invasive cosmetic procedures grows globally, nonsurgical chin augmentation has emerged as a cornerstone in facial contouring. The chin is a small yet powerful determinant of facial harmony. Its retrusion, whether congenital, traumatic, or age-related, can distort balance and undermine self-perception.</p> Purpose <p>With patients increasingly seeking minimally invasive solutions, this systematic review evaluates injectable volumetric techniques for chin augmentation, with a focus on dermal filler-based interventions, and synthesises current evidence on efficacy, safety, and patient satisfaction.</p> Methods <p>Following PRISMA-E guidelines, a comprehensive search across seven databases (1965-2026) identified clinical studies evaluating injectable fillers (and other eligible injectable volumetric agents) for chin augmentation. Study quality and data diversity were analysed, including I<sup>2</sup> heterogeneity.</p> Results <p>Eleven eligible studies comprising 876 patients were analysed. Hyaluronic acid fillers predominated, with follow-ups averaging 12.8 months (SD: 7.7). Over 90% of patients reported satisfaction, supported by photographic and patient-reported assessments. Adverse effects were minor and transient, mainly oedema, bruising, and nodularity.</p> Conclusion <p>Injectable fillers provide effective short-term improvement in chin projection with high patient satisfaction and acceptable safety. However, evidence is heterogeneous and largely non-comparative, limiting conclusions on long-term outcomes. Further controlled studies are required.</p> No Level Assigned <p>This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Injectable Filler-Based Chin Augmentation: A Systematic Review of Non-Surgical Volumetric Techniques

  • 期刊论文

  • 发表日期：

    2026年8月3日

查看全文
  • Debraj Shome,
  • Debalina Bose,
  • Ashwin Prabhughate,
  • Rasesh Shah,
  • Rinky Kapoor

摘要

Background

Facial aesthetics are profoundly influenced by the chin, a central feature that shapes harmony, projection, and perceived attractiveness. As demand for minimally invasive cosmetic procedures grows globally, nonsurgical chin augmentation has emerged as a cornerstone in facial contouring. The chin is a small yet powerful determinant of facial harmony. Its retrusion, whether congenital, traumatic, or age-related, can distort balance and undermine self-perception.

Purpose

With patients increasingly seeking minimally invasive solutions, this systematic review evaluates injectable volumetric techniques for chin augmentation, with a focus on dermal filler-based interventions, and synthesises current evidence on efficacy, safety, and patient satisfaction.

Methods

Following PRISMA-E guidelines, a comprehensive search across seven databases (1965-2026) identified clinical studies evaluating injectable fillers (and other eligible injectable volumetric agents) for chin augmentation. Study quality and data diversity were analysed, including I2 heterogeneity.

Results

Eleven eligible studies comprising 876 patients were analysed. Hyaluronic acid fillers predominated, with follow-ups averaging 12.8 months (SD: 7.7). Over 90% of patients reported satisfaction, supported by photographic and patient-reported assessments. Adverse effects were minor and transient, mainly oedema, bruising, and nodularity.

Conclusion

Injectable fillers provide effective short-term improvement in chin projection with high patient satisfaction and acceptable safety. However, evidence is heterogeneous and largely non-comparative, limiting conclusions on long-term outcomes. Further controlled studies are required.

No Level Assigned

This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.